nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—MTOR—hypertension	0.434	1	CbGaD
Pimecrolimus—CYP3A4—Guanethidine—hypertension	0.0241	0.11	CbGbCtD
Pimecrolimus—CYP3A4—Hydralazine—hypertension	0.0183	0.0837	CbGbCtD
Pimecrolimus—CYP3A4—Guanfacine—hypertension	0.0155	0.0712	CbGbCtD
Pimecrolimus—CYP3A4—Isradipine—hypertension	0.0139	0.0634	CbGbCtD
Pimecrolimus—CYP3A4—Indapamide—hypertension	0.0122	0.0558	CbGbCtD
Pimecrolimus—CYP3A4—Nisoldipine—hypertension	0.0122	0.0558	CbGbCtD
Pimecrolimus—CYP3A4—Eplerenone—hypertension	0.0118	0.0539	CbGbCtD
Pimecrolimus—CYP3A4—Diltiazem—hypertension	0.0118	0.0539	CbGbCtD
Pimecrolimus—CYP3A4—Enalapril—hypertension	0.0105	0.0481	CbGbCtD
Pimecrolimus—CYP3A4—Irbesartan—hypertension	0.00961	0.044	CbGbCtD
Pimecrolimus—CYP3A4—Amlodipine—hypertension	0.00942	0.0431	CbGbCtD
Pimecrolimus—CYP3A4—Felodipine—hypertension	0.00908	0.0416	CbGbCtD
Pimecrolimus—CYP3A4—Nifedipine—hypertension	0.00879	0.0402	CbGbCtD
Pimecrolimus—CYP3A4—Nicardipine—hypertension	0.00865	0.0396	CbGbCtD
Pimecrolimus—CYP3A4—Carvedilol—hypertension	0.00865	0.0396	CbGbCtD
Pimecrolimus—CYP3A4—Propranolol—hypertension	0.00796	0.0364	CbGbCtD
Pimecrolimus—CYP3A4—Clonidine—hypertension	0.00759	0.0348	CbGbCtD
Pimecrolimus—CYP3A4—Atorvastatin—hypertension	0.00677	0.031	CbGbCtD
Pimecrolimus—CYP3A4—Losartan—hypertension	0.00619	0.0283	CbGbCtD
Pimecrolimus—CYP3A4—Verapamil—hypertension	0.00546	0.025	CbGbCtD
Pimecrolimus—MTOR—hindlimb—hypertension	0.00542	0.162	CbGeAlD
Pimecrolimus—MTOR—blood vessel—hypertension	0.00259	0.0774	CbGeAlD
Pimecrolimus—FKBP1A—cardiac ventricle—hypertension	0.00168	0.0501	CbGeAlD
Pimecrolimus—FKBP1A—myocardium—hypertension	0.00158	0.0471	CbGeAlD
Pimecrolimus—MTOR—brainstem—hypertension	0.00142	0.0423	CbGeAlD
Pimecrolimus—CYP3A4—urine—hypertension	0.0014	0.042	CbGeAlD
Pimecrolimus—MTOR—heart—hypertension	0.00122	0.0366	CbGeAlD
Pimecrolimus—MTOR—smooth muscle tissue—hypertension	0.00121	0.0363	CbGeAlD
Pimecrolimus—MTOR—cardiovascular system—hypertension	0.00116	0.0345	CbGeAlD
Pimecrolimus—FKBP1A—adrenal cortex—hypertension	0.00114	0.034	CbGeAlD
Pimecrolimus—MTOR—kidney—hypertension	0.00113	0.0338	CbGeAlD
Pimecrolimus—FKBP1A—heart—hypertension	0.0011	0.0329	CbGeAlD
Pimecrolimus—FKBP1A—smooth muscle tissue—hypertension	0.00109	0.0326	CbGeAlD
Pimecrolimus—FKBP1A—decidua—hypertension	0.00107	0.032	CbGeAlD
Pimecrolimus—FKBP1A—cardiovascular system—hypertension	0.00104	0.031	CbGeAlD
Pimecrolimus—FKBP1A—kidney—hypertension	0.00102	0.0304	CbGeAlD
Pimecrolimus—Everolimus—MTOR—hypertension	0.00101	0.218	CrCbGaD
Pimecrolimus—FKBP1A—cortex of kidney—hypertension	0.00099	0.0296	CbGeAlD
Pimecrolimus—FKBP1A—cardiac atrium—hypertension	0.000942	0.0281	CbGeAlD
Pimecrolimus—MTOR—adrenal gland—hypertension	0.000914	0.0273	CbGeAlD
Pimecrolimus—FKBP1A—medulla oblongata—hypertension	0.000888	0.0265	CbGeAlD
Pimecrolimus—FKBP1A—adrenal gland—hypertension	0.000822	0.0246	CbGeAlD
Pimecrolimus—MTOR—endocrine gland—hypertension	0.000792	0.0237	CbGeAlD
Pimecrolimus—Sirolimus—FGF2—hypertension	0.00074	0.159	CrCbGaD
Pimecrolimus—MTOR—central nervous system—hypertension	0.000714	0.0213	CbGeAlD
Pimecrolimus—FKBP1A—endocrine gland—hypertension	0.000713	0.0213	CbGeAlD
Pimecrolimus—Temsirolimus—MTOR—hypertension	0.000686	0.147	CrCbGaD
Pimecrolimus—FKBP1A—central nervous system—hypertension	0.000642	0.0192	CbGeAlD
Pimecrolimus—Sirolimus—MTOR—hypertension	0.000604	0.13	CrCbGaD
Pimecrolimus—Tacrolimus—MTOR—hypertension	0.000604	0.13	CrCbGaD
Pimecrolimus—CYP3A4—kidney—hypertension	0.000332	0.00993	CbGeAlD
Pimecrolimus—Temsirolimus—CYP3A5—hypertension	0.000327	0.0702	CrCbGaD
Pimecrolimus—Sirolimus—CYP3A5—hypertension	0.000288	0.0618	CrCbGaD
Pimecrolimus—Tacrolimus—CYP3A5—hypertension	0.000288	0.0618	CrCbGaD
Pimecrolimus—CYP3A4—endocrine gland—hypertension	0.000233	0.00696	CbGeAlD
Pimecrolimus—CYP3A4—central nervous system—hypertension	0.00021	0.00627	CbGeAlD
Pimecrolimus—Tacrolimus—ALB—hypertension	0.000109	0.0233	CrCbGaD
Pimecrolimus—Cough—Timolol—hypertension	4.26e-05	0.000238	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Furosemide—hypertension	4.26e-05	0.000237	CcSEcCtD
Pimecrolimus—Arthralgia—Ramipril—hypertension	4.26e-05	0.000237	CcSEcCtD
Pimecrolimus—Abdominal pain—Telmisartan—hypertension	4.25e-05	0.000237	CcSEcCtD
Pimecrolimus—Body temperature increased—Telmisartan—hypertension	4.25e-05	0.000237	CcSEcCtD
Pimecrolimus—Dyspnoea—Losartan—hypertension	4.24e-05	0.000236	CcSEcCtD
Pimecrolimus—Vomiting—Indapamide—hypertension	4.23e-05	0.000236	CcSEcCtD
Pimecrolimus—Vomiting—Diltiazem—hypertension	4.23e-05	0.000236	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	4.23e-05	0.000236	CcSEcCtD
Pimecrolimus—Pain—Furosemide—hypertension	4.22e-05	0.000235	CcSEcCtD
Pimecrolimus—Constipation—Furosemide—hypertension	4.22e-05	0.000235	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betaxolol—hypertension	4.22e-05	0.000235	CcSEcCtD
Pimecrolimus—Rash—Diltiazem—hypertension	4.19e-05	0.000234	CcSEcCtD
Pimecrolimus—Rash—Indapamide—hypertension	4.19e-05	0.000234	CcSEcCtD
Pimecrolimus—Dermatitis—Diltiazem—hypertension	4.19e-05	0.000233	CcSEcCtD
Pimecrolimus—Dermatitis—Indapamide—hypertension	4.19e-05	0.000233	CcSEcCtD
Pimecrolimus—Vomiting—Carvedilol—hypertension	4.19e-05	0.000233	CcSEcCtD
Pimecrolimus—Pain—Betaxolol—hypertension	4.18e-05	0.000233	CcSEcCtD
Pimecrolimus—Constipation—Betaxolol—hypertension	4.18e-05	0.000233	CcSEcCtD
Pimecrolimus—Headache—Diltiazem—hypertension	4.17e-05	0.000232	CcSEcCtD
Pimecrolimus—Headache—Indapamide—hypertension	4.17e-05	0.000232	CcSEcCtD
Pimecrolimus—Pruritus—Valsartan—hypertension	4.16e-05	0.000232	CcSEcCtD
Pimecrolimus—Arthralgia—Timolol—hypertension	4.16e-05	0.000232	CcSEcCtD
Pimecrolimus—Rash—Carvedilol—hypertension	4.15e-05	0.000231	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Perindopril—hypertension	4.15e-05	0.000231	CcSEcCtD
Pimecrolimus—Dermatitis—Carvedilol—hypertension	4.15e-05	0.000231	CcSEcCtD
Pimecrolimus—Angioedema—Lisinopril—hypertension	4.14e-05	0.000231	CcSEcCtD
Pimecrolimus—Pruritus—Olmesartan—hypertension	4.14e-05	0.000231	CcSEcCtD
Pimecrolimus—Vomiting—Doxazosin—hypertension	4.14e-05	0.000231	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Irbesartan—hypertension	4.13e-05	0.00023	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	4.13e-05	0.00023	CcSEcCtD
Pimecrolimus—Hypersensitivity—Clonidine—hypertension	4.13e-05	0.00023	CcSEcCtD
Pimecrolimus—Body temperature increased—Captopril—hypertension	4.13e-05	0.00023	CcSEcCtD
Pimecrolimus—Abdominal pain—Captopril—hypertension	4.13e-05	0.00023	CcSEcCtD
Pimecrolimus—Headache—Carvedilol—hypertension	4.13e-05	0.00023	CcSEcCtD
Pimecrolimus—Rash—Doxazosin—hypertension	4.11e-05	0.000229	CcSEcCtD
Pimecrolimus—Dermatitis—Doxazosin—hypertension	4.1e-05	0.000229	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Hydrochlorothiazide—hypertension	4.1e-05	0.000229	CcSEcCtD
Pimecrolimus—Vomiting—Fosinopril—hypertension	4.09e-05	0.000228	CcSEcCtD
Pimecrolimus—Nausea—Propranolol—hypertension	4.08e-05	0.000227	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Ramipril—hypertension	4.08e-05	0.000227	CcSEcCtD
Pimecrolimus—Oedema—Ramipril—hypertension	4.08e-05	0.000227	CcSEcCtD
Pimecrolimus—Headache—Doxazosin—hypertension	4.08e-05	0.000227	CcSEcCtD
Pimecrolimus—Pain—Losartan—hypertension	4.07e-05	0.000227	CcSEcCtD
Pimecrolimus—Constipation—Losartan—hypertension	4.07e-05	0.000227	CcSEcCtD
Pimecrolimus—Vomiting—Eplerenone—hypertension	4.07e-05	0.000227	CcSEcCtD
Pimecrolimus—Rash—Fosinopril—hypertension	4.06e-05	0.000226	CcSEcCtD
Pimecrolimus—Dermatitis—Fosinopril—hypertension	4.05e-05	0.000226	CcSEcCtD
Pimecrolimus—Vomiting—Nifedipine—hypertension	4.04e-05	0.000225	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Furosemide—hypertension	4.03e-05	0.000225	CcSEcCtD
Pimecrolimus—Rash—Eplerenone—hypertension	4.03e-05	0.000225	CcSEcCtD
Pimecrolimus—Urticaria—Perindopril—hypertension	4.03e-05	0.000225	CcSEcCtD
Pimecrolimus—Headache—Fosinopril—hypertension	4.03e-05	0.000225	CcSEcCtD
Pimecrolimus—Hypersensitivity—Trandolapril—hypertension	4.03e-05	0.000225	CcSEcCtD
Pimecrolimus—Dermatitis—Eplerenone—hypertension	4.03e-05	0.000224	CcSEcCtD
Pimecrolimus—Diarrhoea—Valsartan—hypertension	4.03e-05	0.000224	CcSEcCtD
Pimecrolimus—Vomiting—Verapamil—hypertension	4.02e-05	0.000224	CcSEcCtD
Pimecrolimus—Urticaria—Irbesartan—hypertension	4.02e-05	0.000224	CcSEcCtD
Pimecrolimus—Hypersensitivity—Enalapril—hypertension	4.01e-05	0.000224	CcSEcCtD
Pimecrolimus—Abdominal pain—Perindopril—hypertension	4.01e-05	0.000223	CcSEcCtD
Pimecrolimus—Body temperature increased—Perindopril—hypertension	4.01e-05	0.000223	CcSEcCtD
Pimecrolimus—Diarrhoea—Olmesartan—hypertension	4.01e-05	0.000223	CcSEcCtD
Pimecrolimus—Headache—Eplerenone—hypertension	4.01e-05	0.000223	CcSEcCtD
Pimecrolimus—Rash—Nifedipine—hypertension	4e-05	0.000223	CcSEcCtD
Pimecrolimus—Nervous system disorder—Ramipril—hypertension	4e-05	0.000223	CcSEcCtD
Pimecrolimus—Dermatitis—Nifedipine—hypertension	4e-05	0.000223	CcSEcCtD
Pimecrolimus—Abdominal pain—Irbesartan—hypertension	4e-05	0.000223	CcSEcCtD
Pimecrolimus—Body temperature increased—Irbesartan—hypertension	4e-05	0.000223	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Timolol—hypertension	3.99e-05	0.000222	CcSEcCtD
Pimecrolimus—Oedema—Timolol—hypertension	3.99e-05	0.000222	CcSEcCtD
Pimecrolimus—Rash—Verapamil—hypertension	3.98e-05	0.000222	CcSEcCtD
Pimecrolimus—Urticaria—Hydrochlorothiazide—hypertension	3.98e-05	0.000222	CcSEcCtD
Pimecrolimus—Dermatitis—Verapamil—hypertension	3.98e-05	0.000222	CcSEcCtD
Pimecrolimus—Headache—Nifedipine—hypertension	3.98e-05	0.000222	CcSEcCtD
Pimecrolimus—Pruritus—Clonidine—hypertension	3.97e-05	0.000221	CcSEcCtD
Pimecrolimus—Body temperature increased—Hydrochlorothiazide—hypertension	3.96e-05	0.000221	CcSEcCtD
Pimecrolimus—Abdominal pain—Hydrochlorothiazide—hypertension	3.96e-05	0.000221	CcSEcCtD
Pimecrolimus—Skin disorder—Ramipril—hypertension	3.96e-05	0.000221	CcSEcCtD
Pimecrolimus—Infection—Timolol—hypertension	3.96e-05	0.000221	CcSEcCtD
Pimecrolimus—Headache—Verapamil—hypertension	3.96e-05	0.000221	CcSEcCtD
Pimecrolimus—Hypersensitivity—Telmisartan—hypertension	3.96e-05	0.000221	CcSEcCtD
Pimecrolimus—Cough—Lisinopril—hypertension	3.96e-05	0.00022	CcSEcCtD
Pimecrolimus—Nausea—Indapamide—hypertension	3.95e-05	0.00022	CcSEcCtD
Pimecrolimus—Nausea—Diltiazem—hypertension	3.95e-05	0.00022	CcSEcCtD
Pimecrolimus—Urticaria—Furosemide—hypertension	3.92e-05	0.000218	CcSEcCtD
Pimecrolimus—Nervous system disorder—Timolol—hypertension	3.91e-05	0.000218	CcSEcCtD
Pimecrolimus—Nausea—Carvedilol—hypertension	3.91e-05	0.000218	CcSEcCtD
Pimecrolimus—Abdominal pain—Furosemide—hypertension	3.9e-05	0.000217	CcSEcCtD
Pimecrolimus—Body temperature increased—Furosemide—hypertension	3.9e-05	0.000217	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Losartan—hypertension	3.89e-05	0.000217	CcSEcCtD
Pimecrolimus—Urticaria—Betaxolol—hypertension	3.88e-05	0.000216	CcSEcCtD
Pimecrolimus—Skin disorder—Timolol—hypertension	3.87e-05	0.000216	CcSEcCtD
Pimecrolimus—Pruritus—Trandolapril—hypertension	3.87e-05	0.000216	CcSEcCtD
Pimecrolimus—Nausea—Doxazosin—hypertension	3.87e-05	0.000216	CcSEcCtD
Pimecrolimus—Arthralgia—Lisinopril—hypertension	3.86e-05	0.000215	CcSEcCtD
Pimecrolimus—Body temperature increased—Betaxolol—hypertension	3.86e-05	0.000215	CcSEcCtD
Pimecrolimus—Pruritus—Enalapril—hypertension	3.85e-05	0.000215	CcSEcCtD
Pimecrolimus—Diarrhoea—Clonidine—hypertension	3.84e-05	0.000214	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.83e-05	0.000214	CcSEcCtD
Pimecrolimus—Nausea—Fosinopril—hypertension	3.82e-05	0.000213	CcSEcCtD
Pimecrolimus—Pruritus—Telmisartan—hypertension	3.8e-05	0.000212	CcSEcCtD
Pimecrolimus—Nausea—Eplerenone—hypertension	3.8e-05	0.000212	CcSEcCtD
Pimecrolimus—Urticaria—Losartan—hypertension	3.78e-05	0.000211	CcSEcCtD
Pimecrolimus—Nausea—Nifedipine—hypertension	3.77e-05	0.00021	CcSEcCtD
Pimecrolimus—Body temperature increased—Losartan—hypertension	3.76e-05	0.00021	CcSEcCtD
Pimecrolimus—Abdominal pain—Losartan—hypertension	3.76e-05	0.00021	CcSEcCtD
Pimecrolimus—Nausea—Verapamil—hypertension	3.75e-05	0.000209	CcSEcCtD
Pimecrolimus—Diarrhoea—Trandolapril—hypertension	3.74e-05	0.000209	CcSEcCtD
Pimecrolimus—Vomiting—Valsartan—hypertension	3.74e-05	0.000208	CcSEcCtD
Pimecrolimus—Diarrhoea—Enalapril—hypertension	3.73e-05	0.000208	CcSEcCtD
Pimecrolimus—Hypersensitivity—Irbesartan—hypertension	3.73e-05	0.000208	CcSEcCtD
Pimecrolimus—Vomiting—Olmesartan—hypertension	3.72e-05	0.000207	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Ramipril—hypertension	3.72e-05	0.000207	CcSEcCtD
Pimecrolimus—Rash—Valsartan—hypertension	3.71e-05	0.000207	CcSEcCtD
Pimecrolimus—Dermatitis—Valsartan—hypertension	3.71e-05	0.000207	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Lisinopril—hypertension	3.7e-05	0.000206	CcSEcCtD
Pimecrolimus—Oedema—Lisinopril—hypertension	3.7e-05	0.000206	CcSEcCtD
Pimecrolimus—Pruritus—Captopril—hypertension	3.7e-05	0.000206	CcSEcCtD
Pimecrolimus—Hypersensitivity—Hydrochlorothiazide—hypertension	3.69e-05	0.000206	CcSEcCtD
Pimecrolimus—Rash—Olmesartan—hypertension	3.69e-05	0.000206	CcSEcCtD
Pimecrolimus—Dermatitis—Olmesartan—hypertension	3.69e-05	0.000206	CcSEcCtD
Pimecrolimus—Headache—Valsartan—hypertension	3.69e-05	0.000205	CcSEcCtD
Pimecrolimus—Diarrhoea—Telmisartan—hypertension	3.68e-05	0.000205	CcSEcCtD
Pimecrolimus—Infection—Lisinopril—hypertension	3.68e-05	0.000205	CcSEcCtD
Pimecrolimus—Headache—Olmesartan—hypertension	3.67e-05	0.000204	CcSEcCtD
Pimecrolimus—Paraesthesia—Ramipril—hypertension	3.66e-05	0.000204	CcSEcCtD
Pimecrolimus—Dyspnoea—Ramipril—hypertension	3.64e-05	0.000203	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Timolol—hypertension	3.63e-05	0.000202	CcSEcCtD
Pimecrolimus—Hypersensitivity—Furosemide—hypertension	3.63e-05	0.000202	CcSEcCtD
Pimecrolimus—Hypersensitivity—Betaxolol—hypertension	3.6e-05	0.0002	CcSEcCtD
Pimecrolimus—Skin disorder—Lisinopril—hypertension	3.59e-05	0.0002	CcSEcCtD
Pimecrolimus—Pruritus—Perindopril—hypertension	3.59e-05	0.0002	CcSEcCtD
Pimecrolimus—Paraesthesia—Timolol—hypertension	3.58e-05	0.0002	CcSEcCtD
Pimecrolimus—Pruritus—Irbesartan—hypertension	3.58e-05	0.000199	CcSEcCtD
Pimecrolimus—Diarrhoea—Captopril—hypertension	3.58e-05	0.000199	CcSEcCtD
Pimecrolimus—Vomiting—Clonidine—hypertension	3.57e-05	0.000199	CcSEcCtD
Pimecrolimus—Dyspnoea—Timolol—hypertension	3.56e-05	0.000198	CcSEcCtD
Pimecrolimus—Pruritus—Hydrochlorothiazide—hypertension	3.55e-05	0.000198	CcSEcCtD
Pimecrolimus—Rash—Clonidine—hypertension	3.54e-05	0.000197	CcSEcCtD
Pimecrolimus—Dermatitis—Clonidine—hypertension	3.53e-05	0.000197	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Ramipril—hypertension	3.52e-05	0.000196	CcSEcCtD
Pimecrolimus—Headache—Clonidine—hypertension	3.51e-05	0.000196	CcSEcCtD
Pimecrolimus—Hypersensitivity—Losartan—hypertension	3.51e-05	0.000195	CcSEcCtD
Pimecrolimus—Nausea—Valsartan—hypertension	3.49e-05	0.000195	CcSEcCtD
Pimecrolimus—Pruritus—Furosemide—hypertension	3.49e-05	0.000194	CcSEcCtD
Pimecrolimus—Constipation—Ramipril—hypertension	3.49e-05	0.000194	CcSEcCtD
Pimecrolimus—Nausea—Olmesartan—hypertension	3.48e-05	0.000194	CcSEcCtD
Pimecrolimus—Vomiting—Trandolapril—hypertension	3.48e-05	0.000194	CcSEcCtD
Pimecrolimus—Diarrhoea—Perindopril—hypertension	3.47e-05	0.000193	CcSEcCtD
Pimecrolimus—Vomiting—Enalapril—hypertension	3.46e-05	0.000193	CcSEcCtD
Pimecrolimus—Diarrhoea—Irbesartan—hypertension	3.46e-05	0.000193	CcSEcCtD
Pimecrolimus—Pruritus—Betaxolol—hypertension	3.45e-05	0.000192	CcSEcCtD
Pimecrolimus—Rash—Trandolapril—hypertension	3.45e-05	0.000192	CcSEcCtD
Pimecrolimus—Dermatitis—Trandolapril—hypertension	3.45e-05	0.000192	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Timolol—hypertension	3.44e-05	0.000192	CcSEcCtD
Pimecrolimus—Rash—Enalapril—hypertension	3.43e-05	0.000191	CcSEcCtD
Pimecrolimus—Dermatitis—Enalapril—hypertension	3.43e-05	0.000191	CcSEcCtD
Pimecrolimus—Diarrhoea—Hydrochlorothiazide—hypertension	3.43e-05	0.000191	CcSEcCtD
Pimecrolimus—Headache—Trandolapril—hypertension	3.43e-05	0.000191	CcSEcCtD
Pimecrolimus—Vomiting—Telmisartan—hypertension	3.42e-05	0.00019	CcSEcCtD
Pimecrolimus—Headache—Enalapril—hypertension	3.41e-05	0.00019	CcSEcCtD
Pimecrolimus—Pain—Timolol—hypertension	3.41e-05	0.00019	CcSEcCtD
Pimecrolimus—Rash—Telmisartan—hypertension	3.39e-05	0.000189	CcSEcCtD
Pimecrolimus—Dermatitis—Telmisartan—hypertension	3.38e-05	0.000189	CcSEcCtD
Pimecrolimus—Diarrhoea—Furosemide—hypertension	3.37e-05	0.000188	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Lisinopril—hypertension	3.37e-05	0.000188	CcSEcCtD
Pimecrolimus—Pruritus—Losartan—hypertension	3.37e-05	0.000188	CcSEcCtD
Pimecrolimus—Headache—Telmisartan—hypertension	3.37e-05	0.000188	CcSEcCtD
Pimecrolimus—Diarrhoea—Betaxolol—hypertension	3.34e-05	0.000186	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Ramipril—hypertension	3.34e-05	0.000186	CcSEcCtD
Pimecrolimus—Nausea—Clonidine—hypertension	3.33e-05	0.000186	CcSEcCtD
Pimecrolimus—Paraesthesia—Lisinopril—hypertension	3.32e-05	0.000185	CcSEcCtD
Pimecrolimus—Vomiting—Captopril—hypertension	3.32e-05	0.000185	CcSEcCtD
Pimecrolimus—Dyspnoea—Lisinopril—hypertension	3.3e-05	0.000184	CcSEcCtD
Pimecrolimus—Rash—Captopril—hypertension	3.29e-05	0.000184	CcSEcCtD
Pimecrolimus—Dermatitis—Captopril—hypertension	3.29e-05	0.000183	CcSEcCtD
Pimecrolimus—Headache—Captopril—hypertension	3.27e-05	0.000182	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Timolol—hypertension	3.26e-05	0.000182	CcSEcCtD
Pimecrolimus—Diarrhoea—Losartan—hypertension	3.26e-05	0.000181	CcSEcCtD
Pimecrolimus—Nausea—Trandolapril—hypertension	3.25e-05	0.000181	CcSEcCtD
Pimecrolimus—Urticaria—Ramipril—hypertension	3.24e-05	0.000181	CcSEcCtD
Pimecrolimus—Nausea—Enalapril—hypertension	3.24e-05	0.00018	CcSEcCtD
Pimecrolimus—Vomiting—Perindopril—hypertension	3.23e-05	0.00018	CcSEcCtD
Pimecrolimus—Body temperature increased—Ramipril—hypertension	3.23e-05	0.00018	CcSEcCtD
Pimecrolimus—Abdominal pain—Ramipril—hypertension	3.23e-05	0.00018	CcSEcCtD
Pimecrolimus—Vomiting—Irbesartan—hypertension	3.21e-05	0.000179	CcSEcCtD
Pimecrolimus—Rash—Perindopril—hypertension	3.2e-05	0.000178	CcSEcCtD
Pimecrolimus—Dermatitis—Perindopril—hypertension	3.2e-05	0.000178	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Lisinopril—hypertension	3.19e-05	0.000178	CcSEcCtD
Pimecrolimus—Nausea—Telmisartan—hypertension	3.19e-05	0.000178	CcSEcCtD
Pimecrolimus—Vomiting—Hydrochlorothiazide—hypertension	3.19e-05	0.000178	CcSEcCtD
Pimecrolimus—Rash—Irbesartan—hypertension	3.19e-05	0.000178	CcSEcCtD
Pimecrolimus—Dermatitis—Irbesartan—hypertension	3.19e-05	0.000177	CcSEcCtD
Pimecrolimus—Headache—Perindopril—hypertension	3.18e-05	0.000177	CcSEcCtD
Pimecrolimus—Urticaria—Timolol—hypertension	3.17e-05	0.000177	CcSEcCtD
Pimecrolimus—Headache—Irbesartan—hypertension	3.17e-05	0.000177	CcSEcCtD
Pimecrolimus—Pain—Lisinopril—hypertension	3.16e-05	0.000176	CcSEcCtD
Pimecrolimus—Constipation—Lisinopril—hypertension	3.16e-05	0.000176	CcSEcCtD
Pimecrolimus—Rash—Hydrochlorothiazide—hypertension	3.16e-05	0.000176	CcSEcCtD
Pimecrolimus—Dermatitis—Hydrochlorothiazide—hypertension	3.16e-05	0.000176	CcSEcCtD
Pimecrolimus—Body temperature increased—Timolol—hypertension	3.15e-05	0.000176	CcSEcCtD
Pimecrolimus—Abdominal pain—Timolol—hypertension	3.15e-05	0.000176	CcSEcCtD
Pimecrolimus—Headache—Hydrochlorothiazide—hypertension	3.14e-05	0.000175	CcSEcCtD
Pimecrolimus—Vomiting—Furosemide—hypertension	3.14e-05	0.000175	CcSEcCtD
Pimecrolimus—Rash—Furosemide—hypertension	3.11e-05	0.000173	CcSEcCtD
Pimecrolimus—Dermatitis—Furosemide—hypertension	3.11e-05	0.000173	CcSEcCtD
Pimecrolimus—Vomiting—Betaxolol—hypertension	3.1e-05	0.000173	CcSEcCtD
Pimecrolimus—Nausea—Captopril—hypertension	3.1e-05	0.000173	CcSEcCtD
Pimecrolimus—Headache—Furosemide—hypertension	3.09e-05	0.000172	CcSEcCtD
Pimecrolimus—Rash—Betaxolol—hypertension	3.08e-05	0.000172	CcSEcCtD
Pimecrolimus—Dermatitis—Betaxolol—hypertension	3.08e-05	0.000171	CcSEcCtD
Pimecrolimus—Headache—Betaxolol—hypertension	3.06e-05	0.00017	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Lisinopril—hypertension	3.03e-05	0.000169	CcSEcCtD
Pimecrolimus—Vomiting—Losartan—hypertension	3.03e-05	0.000169	CcSEcCtD
Pimecrolimus—Nausea—Perindopril—hypertension	3.01e-05	0.000168	CcSEcCtD
Pimecrolimus—Hypersensitivity—Ramipril—hypertension	3.01e-05	0.000168	CcSEcCtD
Pimecrolimus—Nausea—Irbesartan—hypertension	3e-05	0.000167	CcSEcCtD
Pimecrolimus—Rash—Losartan—hypertension	3e-05	0.000167	CcSEcCtD
Pimecrolimus—Dermatitis—Losartan—hypertension	3e-05	0.000167	CcSEcCtD
Pimecrolimus—Headache—Losartan—hypertension	2.98e-05	0.000166	CcSEcCtD
Pimecrolimus—Nausea—Hydrochlorothiazide—hypertension	2.98e-05	0.000166	CcSEcCtD
Pimecrolimus—Urticaria—Lisinopril—hypertension	2.94e-05	0.000164	CcSEcCtD
Pimecrolimus—Hypersensitivity—Timolol—hypertension	2.94e-05	0.000164	CcSEcCtD
Pimecrolimus—Nausea—Furosemide—hypertension	2.93e-05	0.000163	CcSEcCtD
Pimecrolimus—Body temperature increased—Lisinopril—hypertension	2.93e-05	0.000163	CcSEcCtD
Pimecrolimus—Abdominal pain—Lisinopril—hypertension	2.93e-05	0.000163	CcSEcCtD
Pimecrolimus—Nausea—Betaxolol—hypertension	2.9e-05	0.000162	CcSEcCtD
Pimecrolimus—Pruritus—Ramipril—hypertension	2.89e-05	0.000161	CcSEcCtD
Pimecrolimus—Nausea—Losartan—hypertension	2.83e-05	0.000157	CcSEcCtD
Pimecrolimus—Pruritus—Timolol—hypertension	2.82e-05	0.000157	CcSEcCtD
Pimecrolimus—Diarrhoea—Ramipril—hypertension	2.79e-05	0.000156	CcSEcCtD
Pimecrolimus—Diarrhoea—Timolol—hypertension	2.73e-05	0.000152	CcSEcCtD
Pimecrolimus—Hypersensitivity—Lisinopril—hypertension	2.73e-05	0.000152	CcSEcCtD
Pimecrolimus—Pruritus—Lisinopril—hypertension	2.62e-05	0.000146	CcSEcCtD
Pimecrolimus—Vomiting—Ramipril—hypertension	2.59e-05	0.000145	CcSEcCtD
Pimecrolimus—Rash—Ramipril—hypertension	2.57e-05	0.000143	CcSEcCtD
Pimecrolimus—Dermatitis—Ramipril—hypertension	2.57e-05	0.000143	CcSEcCtD
Pimecrolimus—Headache—Ramipril—hypertension	2.56e-05	0.000142	CcSEcCtD
Pimecrolimus—Vomiting—Timolol—hypertension	2.54e-05	0.000141	CcSEcCtD
Pimecrolimus—Diarrhoea—Lisinopril—hypertension	2.53e-05	0.000141	CcSEcCtD
Pimecrolimus—Rash—Timolol—hypertension	2.52e-05	0.00014	CcSEcCtD
Pimecrolimus—Dermatitis—Timolol—hypertension	2.51e-05	0.00014	CcSEcCtD
Pimecrolimus—Headache—Timolol—hypertension	2.5e-05	0.000139	CcSEcCtD
Pimecrolimus—Nausea—Ramipril—hypertension	2.42e-05	0.000135	CcSEcCtD
Pimecrolimus—Nausea—Timolol—hypertension	2.37e-05	0.000132	CcSEcCtD
Pimecrolimus—Vomiting—Lisinopril—hypertension	2.35e-05	0.000131	CcSEcCtD
Pimecrolimus—Rash—Lisinopril—hypertension	2.33e-05	0.00013	CcSEcCtD
Pimecrolimus—Dermatitis—Lisinopril—hypertension	2.33e-05	0.00013	CcSEcCtD
Pimecrolimus—Headache—Lisinopril—hypertension	2.32e-05	0.000129	CcSEcCtD
Pimecrolimus—Nausea—Lisinopril—hypertension	2.2e-05	0.000122	CcSEcCtD
Pimecrolimus—MTOR—Disease—CALM1—hypertension	6.58e-06	5.07e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HDAC1—hypertension	6.56e-06	5.06e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STK11—hypertension	6.56e-06	5.06e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOE—hypertension	6.55e-06	5.06e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTT2—hypertension	6.54e-06	5.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MDH1—hypertension	6.54e-06	5.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HYAL1—hypertension	6.54e-06	5.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CDO1—hypertension	6.54e-06	5.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CPS1—hypertension	6.54e-06	5.04e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL10—hypertension	6.5e-06	5.02e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CAV1—hypertension	6.49e-06	5.01e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PLG—hypertension	6.49e-06	5e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—SRC—hypertension	6.48e-06	5e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOA1—hypertension	6.48e-06	5e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SRC—hypertension	6.46e-06	4.98e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SERPINE1—hypertension	6.4e-06	4.94e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADRB2—hypertension	6.31e-06	4.87e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCH1—hypertension	6.24e-06	4.81e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP4F12—hypertension	6.24e-06	4.81e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCE—hypertension	6.23e-06	4.81e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—FGF2—hypertension	6.2e-06	4.78e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RHOA—hypertension	6.18e-06	4.76e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDGFA—hypertension	6.16e-06	4.75e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VAV3—hypertension	6.16e-06	4.75e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PIK3R1—hypertension	6.11e-06	4.72e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—hypertension	6.11e-06	4.72e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—FOS—hypertension	6.11e-06	4.71e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—hypertension	6.11e-06	4.71e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFBR2—hypertension	6.07e-06	4.68e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOTCH1—hypertension	6.05e-06	4.67e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GNB3—hypertension	6.01e-06	4.64e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLCD1—hypertension	5.98e-06	4.61e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AVP—hypertension	5.93e-06	4.58e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—EGFR—hypertension	5.92e-06	4.57e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AKT2—hypertension	5.86e-06	4.52e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GNAS—hypertension	5.85e-06	4.52e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—MYC—hypertension	5.79e-06	4.46e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—hypertension	5.77e-06	4.45e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AHCY—hypertension	5.76e-06	4.44e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP11B1—hypertension	5.76e-06	4.44e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RELA—hypertension	5.75e-06	4.44e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOB—hypertension	5.73e-06	4.42e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTK2—hypertension	5.71e-06	4.4e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—EGFR—hypertension	5.68e-06	4.38e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—EGFR—hypertension	5.66e-06	4.37e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MTOR—hypertension	5.64e-06	4.35e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EDN1—hypertension	5.64e-06	4.35e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL5—hypertension	5.6e-06	4.32e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—INS—hypertension	5.6e-06	4.32e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GBA—hypertension	5.56e-06	4.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—EPHX2—hypertension	5.56e-06	4.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DBH—hypertension	5.56e-06	4.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTM5—hypertension	5.56e-06	4.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX12—hypertension	5.56e-06	4.29e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LPL—hypertension	5.47e-06	4.22e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—H2AFX—hypertension	5.43e-06	4.19e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDGFRB—hypertension	5.42e-06	4.19e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RPS6KB1—hypertension	5.42e-06	4.19e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—hypertension	5.42e-06	4.18e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—AKT2—hypertension	5.41e-06	4.17e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—FGF2—hypertension	5.39e-06	4.16e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP2J2—hypertension	5.38e-06	4.15e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADCY5—hypertension	5.36e-06	4.13e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCG—hypertension	5.32e-06	4.11e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PIK3R1—hypertension	5.32e-06	4.1e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ITGB3—hypertension	5.29e-06	4.08e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCA—hypertension	5.29e-06	4.08e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—YWHAZ—hypertension	5.24e-06	4.05e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ARG1—hypertension	5.23e-06	4.03e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GLS2—hypertension	5.23e-06	4.03e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DECR1—hypertension	5.23e-06	4.03e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—COX5B—hypertension	5.23e-06	4.03e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SPP1—hypertension	5.18e-06	4e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NGF—hypertension	5.18e-06	4e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SERPINE1—hypertension	5.14e-06	3.97e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—BCL2—hypertension	5.12e-06	3.95e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR5—hypertension	5.04e-06	3.89e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCD—hypertension	5.04e-06	3.89e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RELA—hypertension	5e-06	3.86e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—FGF2—hypertension	4.98e-06	3.84e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RHOA—hypertension	4.96e-06	3.83e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALAD—hypertension	4.95e-06	3.82e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2A—hypertension	4.94e-06	3.81e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C3—hypertension	4.93e-06	3.8e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—hypertension	4.91e-06	3.79e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PIK3R1—hypertension	4.91e-06	3.79e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—hypertension	4.9e-06	3.78e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CDKN1A—hypertension	4.89e-06	3.77e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTEN—hypertension	4.88e-06	3.76e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDGFB—hypertension	4.8e-06	3.7e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—FGFR1—hypertension	4.77e-06	3.68e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MAPK8—hypertension	4.77e-06	3.68e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLCE1—hypertension	4.73e-06	3.65e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALDH7A1—hypertension	4.73e-06	3.65e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—STS—hypertension	4.73e-06	3.65e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HIF1A—hypertension	4.7e-06	3.63e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AGT—hypertension	4.68e-06	3.61e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EP300—hypertension	4.65e-06	3.59e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CALM1—hypertension	4.6e-06	3.55e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—hypertension	4.59e-06	3.54e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOE—hypertension	4.59e-06	3.54e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—hypertension	4.55e-06	3.51e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CAV1—hypertension	4.55e-06	3.51e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOA1—hypertension	4.54e-06	3.5e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP4A11—hypertension	4.53e-06	3.5e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ARG2—hypertension	4.53e-06	3.5e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CBS—hypertension	4.53e-06	3.5e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—hypertension	4.52e-06	3.49e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SRC—hypertension	4.52e-06	3.49e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—KDR—hypertension	4.5e-06	3.47e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—hypertension	4.49e-06	3.46e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—XDH—hypertension	4.44e-06	3.43e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—hypertension	4.4e-06	3.4e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGIS—hypertension	4.36e-06	3.36e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP3A5—hypertension	4.36e-06	3.36e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC5A2—hypertension	4.36e-06	3.36e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—hypertension	4.35e-06	3.36e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—FN1—hypertension	4.33e-06	3.34e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—F2—hypertension	4.33e-06	3.34e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCB—hypertension	4.33e-06	3.34e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CDKN1A—hypertension	4.25e-06	3.28e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTEN—hypertension	4.24e-06	3.27e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOTCH1—hypertension	4.23e-06	3.27e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—TPH1—hypertension	4.21e-06	3.25e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—UCP3—hypertension	4.21e-06	3.25e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCC1—hypertension	4.21e-06	3.25e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HSD11B1—hypertension	4.21e-06	3.25e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—UCP2—hypertension	4.21e-06	3.25e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—AKT1—hypertension	4.2e-06	3.24e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—MAPK8—hypertension	4.15e-06	3.2e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC2A3—hypertension	4.08e-06	3.15e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALAS1—hypertension	4.08e-06	3.15e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP11B2—hypertension	4.08e-06	3.15e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MYC—hypertension	4.05e-06	3.13e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EP300—hypertension	4.04e-06	3.12e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—hypertension	4.04e-06	3.12e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—AKT1—hypertension	4.03e-06	3.11e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HSD3B1—hypertension	4.02e-06	3.1e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADA—hypertension	4.02e-06	3.1e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—AKT1—hypertension	4.01e-06	3.1e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EGFR—hypertension	3.96e-06	3.06e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AQP1—hypertension	3.96e-06	3.06e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—FADS1—hypertension	3.96e-06	3.06e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—POMC—hypertension	3.94e-06	3.04e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SRC—hypertension	3.93e-06	3.03e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CDKN1A—hypertension	3.92e-06	3.03e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—INS—hypertension	3.92e-06	3.02e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTEN—hypertension	3.92e-06	3.02e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL2—hypertension	3.86e-06	2.98e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CA9—hypertension	3.85e-06	2.97e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—TBXAS1—hypertension	3.85e-06	2.97e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF1—hypertension	3.79e-06	2.93e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AKT2—hypertension	3.79e-06	2.92e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX15—hypertension	3.75e-06	2.9e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX5AP—hypertension	3.75e-06	2.9e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EP300—hypertension	3.73e-06	2.88e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LHB—hypertension	3.66e-06	2.83e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HADHA—hypertension	3.66e-06	2.83e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SRC—hypertension	3.63e-06	2.8e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SERPINE1—hypertension	3.6e-06	2.78e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—KCNJ11—hypertension	3.58e-06	2.76e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HSD3B2—hypertension	3.58e-06	2.76e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LPA—hypertension	3.58e-06	2.76e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—FGF2—hypertension	3.49e-06	2.69e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RHOA—hypertension	3.47e-06	2.68e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EGFR—hypertension	3.45e-06	2.66e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PIK3R1—hypertension	3.44e-06	2.65e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—hypertension	3.44e-06	2.65e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LRP2—hypertension	3.43e-06	2.65e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP2C18—hypertension	3.43e-06	2.65e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—hypertension	3.33e-06	2.57e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HSPG2—hypertension	3.31e-06	2.55e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—MYC—hypertension	3.25e-06	2.51e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—hypertension	3.25e-06	2.5e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RELA—hypertension	3.24e-06	2.5e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX5—hypertension	3.19e-06	2.46e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GLP1R—hypertension	3.19e-06	2.46e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EGFR—hypertension	3.18e-06	2.46e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—hypertension	3.05e-06	2.35e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—hypertension	3.05e-06	2.35e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALDH2—hypertension	2.92e-06	2.25e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HBA1—hypertension	2.85e-06	2.2e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP11A1—hypertension	2.83e-06	2.18e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AKT1—hypertension	2.81e-06	2.17e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC9A1—hypertension	2.78e-06	2.14e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTT1—hypertension	2.78e-06	2.14e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—hypertension	2.76e-06	2.13e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CDKN1A—hypertension	2.75e-06	2.12e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCLC—hypertension	2.75e-06	2.12e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CETP—hypertension	2.75e-06	2.12e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTEN—hypertension	2.74e-06	2.12e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MAPK8—hypertension	2.68e-06	2.07e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—hypertension	2.65e-06	2.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP17A1—hypertension	2.63e-06	2.03e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EP300—hypertension	2.61e-06	2.02e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS1—hypertension	2.6e-06	2.01e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ENO1—hypertension	2.6e-06	2.01e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SRC—hypertension	2.54e-06	1.96e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CTGF—hypertension	2.51e-06	1.93e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT2—hypertension	2.48e-06	1.92e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HMGCR—hypertension	2.48e-06	1.92e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—hypertension	2.48e-06	1.91e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—hypertension	2.45e-06	1.89e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AKT1—hypertension	2.44e-06	1.89e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADRA2A—hypertension	2.43e-06	1.87e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MYC—hypertension	2.28e-06	1.76e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—TH—hypertension	2.27e-06	1.75e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—hypertension	2.27e-06	1.75e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CALM2—hypertension	2.27e-06	1.75e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—AKT1—hypertension	2.26e-06	1.74e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EGFR—hypertension	2.23e-06	1.72e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC2A4—hypertension	2.21e-06	1.71e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCG—hypertension	2.21e-06	1.71e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT1—hypertension	2.14e-06	1.65e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—STK11—hypertension	2.08e-06	1.61e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP19A1—hypertension	2.08e-06	1.61e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—COMT—hypertension	1.93e-06	1.49e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARGC1A—hypertension	1.91e-06	1.47e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GNB3—hypertension	1.91e-06	1.47e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HMOX1—hypertension	1.9e-06	1.46e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CAT—hypertension	1.87e-06	1.45e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—hypertension	1.87e-06	1.44e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GNAS—hypertension	1.86e-06	1.43e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOB—hypertension	1.82e-06	1.4e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTM1—hypertension	1.77e-06	1.36e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LPL—hypertension	1.74e-06	1.34e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—hypertension	1.71e-06	1.32e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADCY5—hypertension	1.7e-06	1.31e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GPX1—hypertension	1.69e-06	1.31e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PRKCA—hypertension	1.68e-06	1.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP1A1—hypertension	1.68e-06	1.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CD36—hypertension	1.65e-06	1.27e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AKT1—hypertension	1.58e-06	1.22e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MTHFR—hypertension	1.56e-06	1.21e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARA—hypertension	1.53e-06	1.18e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AGT—hypertension	1.49e-06	1.15e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CALM1—hypertension	1.46e-06	1.13e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOE—hypertension	1.46e-06	1.12e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CAV1—hypertension	1.44e-06	1.11e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOA1—hypertension	1.44e-06	1.11e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARG—hypertension	1.27e-06	9.78e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—POMC—hypertension	1.25e-06	9.65e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—INS—hypertension	1.24e-06	9.59e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—hypertension	1.14e-06	8.79e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—hypertension	1.09e-06	8.41e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PIK3R1—hypertension	1.09e-06	8.41e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—hypertension	9.97e-07	7.69e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTEN—hypertension	8.7e-07	6.71e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—EP300—hypertension	8.29e-07	6.4e-06	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AKT1—hypertension	5.01e-07	3.87e-06	CbGpPWpGaD
